Morphometric aspects of the articular cartilage of rats treated with low-level laser therapy and exercise in a rheumatoid arthritis model

INTRODUCTION: Rheumatoid arthritis (RA) is classified as an autoimmune, chronic disease affecting diarthrodial joints and periarticular structures. OBJECTIVE: To evaluate whether low-intensity laser treatment (LLLT) and/or exercise reduce the deleterious effects of tissue in a rheumatoid arthritis model. METHODS: 128 rats were divided into two inflammatory periods: acute (7 days) and chronic (28 days) and subdivided into control, injury and treatment. The protocol with Freund's Complete Adjuvant was used in two inoculations, one intradermal and one intraarticular in the tibiofemoral joint, the control animals received saline solution. For treatment, LLLT 660 nm, 5 J/cm² was used in the sensitized joint and climbing exercise in stairways with an overload of 100 grams. After the experimental period, the animals were euthanized and the joints were prepared for morphometric analysis of the total thickness, superficial, deep, and cellular density of the articular cartilage. Generalized Linear Models with Sidak post-test were chosen. RESULTS: The control group was found to be different from the lesion group with greater joint cartilage thickness, andthe animals treated with exercise alone increased the joint cartilage compared to thecontrol group. CONCLUSION: The animals treated with laser association and exercise showed improvement in the morphometric aspects of the articular cartilage.

Fosfato de cromo (III) marcado con diferentes radionúclidos para uso en radiosinoviortesis / Chromium (III) labelled with several radionuclidesphosphate for use in radiosynoviothersis

Introducción: la radiosinoviortesis se utiliza en el tratamiento de la sinovitis crónica, complicación frecuente en enfermedades sistémicas como artritis reumatoide y hemofilia. En la práctica clínica internacional se emplean diferentes coloides y suspensiones radiactivas, pero su número es reducido y su disponibilidad limitada. Objetivo: obtención y caracterización físico-química de suspensiones de fosfato de cromo (III) marcadas con radionúclidos como potenciales radiofármacos para uso en radiosinoviortesis. Métodos: las suspensiones se obtuvieron por síntesis química, los radionúclidos se añadieron al inicio de la reacción o después de finalizada esta. El tamaño de partículas se estimó mediante microscopia óptica y filtración por membranas. Asimismo se evaluó por espectrofotometría la estabilidad de la suspensión al ser resuspendida en distintos medios. La pureza radioquímica se determinó por cromatografía de papel. Resultados: se obtuvo y caracterizó una suspensión de fosfato de cromo (III). El producto obtenido presentó un tamaño de partículas predominante entre 0,8-5 µm y que al ser suspendidas en solución de gelatina al 2 por ciento en tampón acetato 1 mg/mL no sedimentó en menos de 3 h. Se estableció la tecnología para la obtención de formulaciones de fosfato de cromo (III) marcado con 32P e 90Y y se demostró la factibilidad de marcar la suspensión obtenida con otros radionúclidos trivalentes como 177Lu y 68Ga. Conclusiones: los resultados permiten considerar al fosfato de cromo (III) una suspensión base para la obtención de radiofármacos para uso en radiosinoviortesis en diferentes articulaciones, en función de las características físico-nucleares de los radionúclidos que se empleen

Introduction: radiosynoviorthesis is used in treating chronic synovitis, a frequent complication of some systemic diseases as rheumatoid arthritis and hemophilia. There are different colloids and radioactive suspensions recommended in the international clinical practice, but the number is reduced and the availability limited. Objective: obtaining and physical-chemical characterization of suspensions of chromium phosphate (III) labeled with several radionuclides as potential radiopharmaceuticals for using in radiosynoviorthesis. Methods: the suspensions were obtained by chemical synthesis. Radionuclides were added at the beginning or after concluding the reaction. The particle size was estimated by means of optic microscopy and membrane filtration. Similarly, the stability of suspension when re-suspended in several media was evaluated by spectrophotometry. The radiochemical purity was determined by paper chromatography. Results: a suspension of chromium (III) phosphate was obtained and characterized. It was found that the obtained product had a predominant particle size range of 0,8 to 5 µm and that when suspended in 2 percent gelatin solution in 1mg/ml acetate buffer, it settled in no less than 3 hours. Technologies for the preparation of radiopharmaceuticals of Chromium (III) Phosphate labeled with 32P and 90Y were described. There was demonstrated the feasibility of labeling the obtained suspension with other trivalent radionuclides such as 177Lu and 68Ga. Conclusions: the results allow considering the obtained Chromium (III) Phosphate suspension as a matrix for the preparation of radiopharmaceuticals to be used in radiosinoviorthesis aimed at various joints, depending on the physical and nuclear characteristics of the radionuclides

Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial

OBJECTIVES: The aim of the present study was to investigate the effectiveness of Samarium153-particulate hydroxyapatite radiation synovectomy in rheumatoid arthritis patients with chronic knee synovitis. METHODS: Fifty-eight rheumatoid arthritis patients (60 knees) with chronic knee synovitis participated in a controlled double-blinded trial. Patients were randomized to receive either an intra-articular injection with 40 mg triamcinolone hexacetonide alone (TH group) or 40 mg triamcinolone hexacetonide combined with 15 mCi Samarium153-particulate hydroxyapatite (Sm/TH group). Blinded examination at baseline (T0) and at 1 (T1), 4 (T4), 12 (T12), 32 (T32), and 48 (T48) weeks post-intervention were performed on all patients and included a visual analog scale for joint pain and swelling as well as data on morning stiffness, flexion, extension, knee circumference, Likert scale of improvement, percentage of improvement, SF-36 generic quality of life questionnaire, Stanford Health Assessment Questionnaire (HAQ), Lequesne index, use of non-steroidal anti-inflammatory drugs or oral corticosteroids, events and adverse effects, calls to the physician, and hospital visits. RESULTS: The sample was homogeneous at baseline, and there were no withdrawals. Improvement was observed in both groups in relation to T0, but no statistically significant differences between groups were observed regarding all variables at the time points studied. The Sm/TH group exhibited more adverse effects at T1 (p<0.05), but these were mild and transitory. No severe adverse effects were reported during follow-up. CONCLUSION: Intra-articular injection of Samarium153-particulate hydroxyapatite (15 mCi) with 40 mg of triamcinolone hexacetonide is not superior to triamcinolone hexacetonide alone for the treatment of knee synovitis in patients with rheumatoid arthritis at 1 y of follow-up.

Sinovectomía radioactiva con yttrium 90 y rhenium 186, en artritis reumatoídea: seguimiento a largo plazo y efecto en la membrana sinovial / Radiation synovectomy with yttrium 90 and rhenium 186 in rheumatoid arthritis: long term follow up and effects on synovial membrane

Despite the progress in the treatment of rheumatoid arthritis (RA), many patients continue to suffer from persistent and painful synovitis. We assessed the clinical results of 64 intraarticular injections of Yttrium 90 in the knee and 56 injections of Rhenium 186 in the wrist in 71 patients with RA, older than 40 years, without relief of synovitis after six months of systemic or local treatment and with a radiological stage I or II of the joints. We obtained good results in 75 percent of knees and 100 of wrists during a follow up period of 8 to 60 months. A repeat histological examination of the synovial membrane of 14 joints in which good results were obtained disclosed a reduction in inflammation and transitory synovial cell hyperplasia that ended in a dense fibrosis. It is concluded that radiation synovectomy continues to be an effective therapy for selected patients with RA and synovitis. The observed histopathological changes may aid the interpretation of magnetic resonance imaging of the treated joints

Láser y artritis reumatoide / Laser and rheumatoid arthritis

Se estudiaron 40 pacientes de uno y otro sexos con artritis reumatoide, toma articular y vírgenes de tratamiento, diagnosticados en el Instituto de Reumatología. Se aplicó laserterapia combinada helio-neón e infrarrojo en barrido y focal en 2 ciclos de 20 sesiones cada uno, separados por un período de descanso de un mes. Los pacientes se evaluaron antes del tratamiento y después de este mediante criterios clínicos (inflamación articular con cinta métrica o anillo de joyero, amplitud articular con goniómetro, tiempo de marcha -15 metros-minutos-, fuerza de puño, dolor mediante escala visual del dolor y rigidez matinal) y humorales (velocidad de eritrosedimentación, proteína C-reactiva y factor reumatoideo). Además al final del tratamiento se aplicó la escala de Long-Range (capacidad para la independencia). Se obtuvo una mejoría significativa (p<0,05) con el tratamiento lo que permitió a los pacienres mejorar tanto su disposición como su capacidad para las actividades de la vida diaria, social y laboral